Last updated on April 21, 2014 at 7:52 EDT

Latest Genetic Alliance UK Stories

2013-04-09 08:29:50

New findings reveal the substantial burden of rare diseases due to lack of resources, financial challenges and emotional unrest LEXINGTON, Mass., April 9, 2013 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) today launched a Rare Disease Impact Report, which uncovers the health, psycho-social, and economic impact of rare diseases on patient and medical communities in the United States (US) and United Kingdom (UK). The report, developed in collaboration with an external advisory...

2012-11-19 12:26:44

LEXINGTON, Mass., Nov. 19, 2012 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) today announced a new initiative - the Shire Rare Disease Impact Report - to research the health, psycho-social, societal and economic impact of rare diseases in patient and medical communities. Comprehensive surveys of patients, caregivers, physicians, payors and thought leaders in the United States and the United Kingdom are underway. Survey results will be published and available in the first half of 2013....